MeƱoza, Bb Boy 1 .
HRN: 21-99-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/27/2022
10/04/2022
IVTT
32mg
Q12
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes